JDRF Blog

Latest in Leadership

  • A Team in Boston Trying to Prevent Type 1 Diabetes

    October 29, 2019

    JDRF is funding work on multiple ways to delay or prevent the onset of type 1 diabetes (T1D). This team thinks fat...

  • One Scientist’s Plan to Regenerate Beta Cells in Boston

    October 22, 2019

    Can we internally regenerate and protect beta cells, and therefore find cures for type 1 diabetes (T1D)? One scientist thinks so. Bridget...

  • Get To Know the Key People Behind Beta Cell Replacement Therapy in Boston

    October 15, 2019

    Join us for an inside look at the collaborations and skills that researchers in Boston are using to tackle the complex task...

  • Join Us "Inside the Lab at Boston"

    October 8, 2019

    The work of type 1 diabetes (T1D) researchers is so compelling and full of hope. But it also is a bit shrouded...

  • JDRF Names Aaron Kowalski New President and CEO

    April 9, 2019

    Chief Mission Officer to assume leadership baton from Derek Rapp After a thorough national search, the JDRF International Board of Directors has...

  • JDRF Leaders Jeff Plumer and Sanjoy Dutta Join Editorial Advisory Boards of Two Top Diabetes Publications

    April 3, 2019

    Two of the world’s most respected and trusted health publications have tapped JDRF to serve as an expert voice on their advisory...

  • Testimony of Dr. Aaron Kowalski, Chief Mission Officer, JDRF House Energy & Commerce Committee Oversight And Investigations Subcommittee

    April 2, 2019

    ‘PRICED OUT OF A LIFESAVING DRUG: THE HUMAN IMPACT OF RISING INSULIN COSTS’ Chairwoman DeGette, Ranking Member Guthrie, Chairman Pallone, Ranking Member...

  • Long-time JDRF Supporter Jon Platt Receives National Honor

    October 11, 2018

    For his devotion and dedication to so many, including the JDRF, music mogul Jon Platt today was presented the 2018 Spirit of...

  • Recognize. Recharge. Repeat. Appreciating Our Shared Success.

    July 30, 2018

    Whenever the JDRF community gathers, one thing remains clear: our singular focus on the fight to end type 1 diabetes (T1D) has...